Plant Health Care PLC
13 April 2005
Press Release
For immediate release: 13 April 2005
Plant Health Care wins contract to restore former coal mine sites to forested
land in Wyoming
Plant Health Care plc ('PHC' or the 'Company'), the leading supplier of natural
products for plants and soil, has been awarded a Professional Services Contract
for a three-year abandoned mine land reclamation project in the State of
Wyoming. The contract has a minimum value of $510,000 but it is expected that
the total revenues could be significantly greater over the 3 year period. Over
200 abandoned coal mine sites will be reclaimed to create farm land, parks and
other green spaces.
PHC Reclamation, Inc. ('PHC-REC'), the Company's wholly owned reclamation
subsidiary, has been contracted by the Department of Environmental Quality/
Abandoned Mine Land Division ('AML') to provide professional engineering and
design services for a number of abandoned coal mine sites which pose hazards to
public health and safety, or constitute an environmental hazard. The primary
areas of concern consist of abandoned coal mines located in the Sheridan,
Johnson, Campbell, Weston and Crook Counties of Northeast Wyoming.
PHC-REC has a well-known reputation as one of the foremost land reclamation
companies in the United States and for excellence in engineering, design, and
construction management, and was the 2004 recipient of the coveted People's
Choice Award for best national reclamation project presented by the United
States Department of the Interior, Office of Surface Mining. Since 1997 PHC-REC
has successfully restored over 10,000 acres of abandoned land including 26 sites
in the State of Wyoming.
Turnover for PHC-REC for the year ended 31 December 2004 was in line with
forecasts. Revenue from this contract will commence during 2005 and is expected
to continue for the following 3 years.
CEO of PHC, John Brady added: 'We are proud of the work we have done in Wyoming,
Utah and Montana over the past seven years and we are confident that this
project will be as successful as those before it. The Reclamation business is
one of our main sectors and we will continue to look for opportunities in other
areas of the United States and also in Europe. The market for land reclamation
is worth billions of dollars in the US alone and PHC is well positioned to
capture an increasing market share.'
For further information please contact:
Plant Health Care plc Tavistock Communications
John Brady, CEO Jeremy Carey/Katy Pratt/ Christian Taylor-Wilkinson
Tel: 001 603 525 3702 Tel: 020 7920 3150
Steve Whitcomb Email: kpratt@tavistock.co.uk
Tel: 001 412 826 5488 Email: ctaylor-wilkinson@tavistock.co.uk
Notes to Editors
About PHC
Plant Health Care plc is a leading provider of natural products for plants and
soil. Established in 1995 in Pittsburgh (Pennsylvania) in the United States, PHC
currently has approximately 60 employees and has operations in the US, Mexico,
UK, Spain, and the Netherlands with technical support in Austria. The Group has
two principal operating subsidiaries in the US - PHC Inc (PA) and PHC-REC. The
Company listed on the AIM market of the London Stock Exchange in July 2004.
PHC's products are aimed at the horticulture, agriculture, turf grass,
commercial landscaping, forestry and land reclamation industries and are both
environmentally beneficial and on the whole more cost effective than synthetic
chemical alternatives. Through the commercialisation of these products, PHC is
capitalising on current long-term trends toward natural systems and biological
products for plant care and soil and water management uses.
PHC-REC is an environmental and reclamation engineering consulting firm which
provides engineering and design services for reclamation lands disturbed by
mining, construction, and other activities. PHC-REC are the recognized leader in
the use of biologically based solutions using mycorrhizal fungi and bacteria for
the establishment of trees, shrubs, and grasses on these disturbed lands.
PHC-REC was established in 1997 to exploit PHC's products and technology.
This information is provided by RNS
The company news service from the London Stock Exchange
EFE
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.